佩拉格拉:4个D和8个点
1Professor of Neurology in Birmingham, UK.
Advances in clinical neuroscience & rehabilitation : ACNR
|December 21, 2023
概括
皮拉格拉,一种与贫困相关的疾病,提供了关于饮食中尼古丁胺和NAD平衡的教训. 高的尼古丁胺胺摄入量可以破坏NAD水平,可能导致一种新的超维生素症-B3.
科学领域:
- 营养科学 营养科学
- 生物化学 生物化学
- 公共卫生 公共卫生
背景情况:
- 皮拉格拉,一个历史上与贫困相关的疾病,经常被忽视.
- 来自佩拉格拉的经验教训对于理解饮食中的尼古丁胺和尼古丁胺氨基二核酸 (NAD) 恒温是很重要的.
- 由于基因毒性和其他压力而导致的饮食不良或增加的NAD消耗,NAD平衡可以受到干扰.
研究的目的:
- 重新审视关于营养缺乏及其更广泛的健康影响的贝拉格拉的教训.
- 为了探索超出简单的饮食缺乏的NAD破坏的机制.
- 调查高剂量尼古丁胺胺补充剂可能产生的不良影响.
主要方法:
- 关于贝拉格拉和维生素B3代谢的历史和当前文献的综述.
- 分析涉及尼古丁胺,NAD和相关酶的生化途径.
- 检查基因毒性和其他压力对NAD水平的影响.
主要成果:
- 高剂量的尼古丁胺可以抑制消耗NAD的酶.
- 在高尼古丁胺胺摄入时,观察到尼古丁胺胺-n-甲基转移酶 (NNMT) 的过度诱导.
- 这些干扰为一种新型的高维他命症-B3.3提供了潜在的机制.
结论:
- 佩拉格拉的课程扩展到理解饮食,压力和NAD代谢的复杂相互作用.
- 尼古丁胺胺的高摄入量可能会导致不良健康影响,包括甲基组的破坏.
- 需要进一步的研究来了解超维生素症的全部含义-B3.
相关概念视频
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Pleiotropy
40.5K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.5K
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Disorders of the Nervous Tissue
1.3K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.3K
Cardiovascular System Abnormal Findings I: Inspection and Palpation
403
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Abnormal findings observed during an inspection
403
Assessment of the Cardiovascular System II: Inspection
261
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
261


